Publications by authors named "Nektaria Dimopoulos"

Claim this Profile
M
Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro.
Craig Gedye, Tracy Cardwell, Nektaria Dimopoulos, Bee Shin Tan, Heather Jackson

Stem Cell Rev Rep· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma.
Oliver Klein, Ian D Davis, Grant A McArthur, Li Chen, Andrew Haydon, Nektaria Dimopoulos

Cancer Immunol Immunother· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells.
Laura J Vella, Anupama Pasam, Nektaria Dimopoulos, Miles Andrews, Ashley Knights

Cancer Immunol Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen.
Rona Y Zhao, Nicole A Mifsud, Kun Xiao, Kok-Fei Chan, Sara Oveissi, Nektaria Dimopoulos

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™.
Theo Nicholaou, Weisan Chen, Ian D Davis, Heather M Jackson, Nektaria Dimopoulos

Cancer Immunol Immunother· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melan-A-specific cytotoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4.
Oliver Klein, Lisa M Ebert, Theo Nicholaou, Judy Browning, Sarah E Russell, Nektaria Dimopoulos

Clin Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma.
Theo Nicholaou, Lisa M Ebert, Ian D Davis, Grant A McArthur, Heather Jackson, Nektaria Dimopoulos

Clin Cancer Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design.
Lisa M Ebert, Yu Chih Liu, Craig S Clements, Neil C Robson, Heather M Jackson, Nektaria Dimopoulos

Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining MHC tetramer and intracellular cytokine staining for CD8(+) T cells to reveal antigenic epitopes naturally presented on tumor cells.
Nektaria Dimopoulos, Heather M Jackson, Lisa Ebert, Philippe Guillaume, Immanuel F Luescher

J Immunol Methods· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors.
Fraser M Rogerson, Yi-Zhou Yao, Romi E Elsass, Nektaria Dimopoulos, Brian J Smith

Mol Endocrinol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
Ian D Davis, Qiyuan Chen, Leone Morris, Juliet Quirk, Maureen Stanley, Nektaria Dimopoulos

J Immunother· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.
Heather Jackson, Nektaria Dimopoulos, Nicole A Mifsud, Tsin Yee Tai, Qiyuan Chen

J Immunol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination.
Qiyuan Chen, Heather Jackson, Mark Shackleton, Phillip Parente, Wendie Hopkins, Nektaria Dimopoulos

Cancer Immun· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal in the immunodominance hierarchy in secondary CD8+ T cell responses to influenza A virus: roles for cross-presentation and lysis-independent immunodomination.
Weisan Chen, Ken Pang, Kelly-Anne Masterman, Gina Kennedy, Sameh Basta, Nektaria Dimopoulos

J Immunol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.
Mark Shackleton, Ian D Davis, Wendie Hopkins, Heather Jackson, Nektaria Dimopoulos

Cancer Immun· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples.
Heather M Jackson, Nektaria Dimopoulos, Qiyuan Chen, Tina Luke, Tsin Yee Tai

J Immunol Methods· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.
Ian D Davis, Weisan Chen, Heather Jackson, Phillip Parente, Mark Shackleton, Nektaria Dimopoulos

Proc Natl Acad Sci U S A· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.
Qiyuan Chen, Heather Jackson, Phillip Parente, Tina Luke, Mark Rizkalla, Nektaria Dimopoulos

Proc Natl Acad Sci U S A· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.
Weisan Chen, Kelly-Anne Masterman, Sameh Basta, S M Mansour Haeryfar, Nektaria Dimopoulos

Eur J Immunol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis